Clinical Trials Logo

Fractures, Bone clinical trials

View clinical trials related to Fractures, Bone.

Filter by:

NCT ID: NCT05079555 Completed - Hip Fractures Clinical Trials

Effect of a Robotic Platform for Hip Fracture Rehab

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Hip fracture is one of the most common traumas associated with falls in the elderly, severely affecting the patient's mobility and independence. The treatment involves hospitalization and prolonged rehabilitation periods with high costs which are associated with an increased mortality rate due to health complications. In recent years, the use of robotic applications has proven to be effective in gait rehabilitation, especially for neurological disorders. However, there is a lack of research in robotic rehabilitation focused on the hip fracture of elderly people. This study presents the validation of a novel robotic platform for hip rehabilitation called SWalker aimed at improving the rehabilitation of this condition in comparison with conventional rehabilitation.

NCT ID: NCT05075135 Completed - Clinical trials for Distal Radius Fracture

Acceptability and Safety of 3D Printed Wrist-based Splints

3D-splinting
Start date: August 9, 2021
Phase: N/A
Study type: Interventional

Non-invasiveness, avoidance of complications and comfort are important issues in the clinical management of conservatively treated distal radius and scaphoid fractures. To date, applying a plaster cast for approximately 6 weeks of immobilization is the gold standard. However, new 3D-technologies such as the design of Patient Specific Anatomical Braces (PSAB) will lead to a new paradigm of treatment. Swibrace has developed such anatomical, light, elegant and yet resistant braces. First, the fractured limb is scanned, the data then sent to a specifically designed software, printed in a 3D-printer and finally sent to the hospital for the patient's fitting. As these PSAB have not yet been tested on patients, the primary purpose of this study is to evaluate whether patient satisfaction with a 3D-printed PSAB differs from the one of traditionally treated patients in a plaster cast. (A pre-clinical study will be conducted with 10 healthy volunteers testing the 3D splint for 72h. Only if splint satisfaction will be ≥ 70% as measured by the self-designed "Adult Rated Splint Evaluation Questionnaire" (ARSEQ), the 3D splint will be tested in patients. Otherwise, adjustments to the splint will be made based on the healthy volunteers' feedback prior to its testing in patients.)

NCT ID: NCT05072847 Completed - Clinical trials for Pertrochanteric Fracture

Introduction of the ADAPT System in an Orthopedic Department

ADAPTintro
Start date: March 1, 2021
Phase:
Study type: Observational

The ADAPT system by Stryker is introduced in the orthopedic department (at Aarhus University Hospital). Following the introduction of the ADAPT system all pertrochanteric fractures operated with a gamma3 nail by stryker are operated with the use of the ADAPT system. Following surgery the operating surgeon fill out a questionaire on the use of ADAPT.

NCT ID: NCT05065684 Completed - Long Bone Non-union Clinical Trials

Effect of rhBMP-2 or rhBMP-7 on Long Bone Fractures and Non-unions.

Start date: January 2005
Phase:
Study type: Observational

Delayed fracture healing continues to cause significant patient morbidity and economic burden to society. Biological stimulation of acute fractures and non-unions includes application of rhBMP-2 and rhBMP-7. However, BMP use continues to be a matter of controversy as literature shows scarce evidence for treatment effectiveness. The aim of this study is to compare acute fractures and non-unions in the long bones humerus, femur and tibia with and without BMP treatment of acute fractures. Furthermore, the investigators want to identify complications and risk factors on union-rate and time to union.

NCT ID: NCT05058443 Completed - Clinical trials for Osteoporotic Vertebral Compression Fracture

Denosumab and Osteoporotic Vertebral Compression Fracture

Start date: January 6, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

This study aimed to investigate the effect of denosumab on bone mineral density(BMD), bone turnover markers(BTMs), functional status, secondary fracture rate, and adverse effects in osteoporotic vertebral compression fracture (OVCF) patients after vertebroplasty during a 12-month follow-up period.

NCT ID: NCT05039879 Completed - Hip Fractures Clinical Trials

Life Improving Factors After a Hip Fracture

LIFF
Start date: September 6, 2021
Phase:
Study type: Observational

The primary objective of the proposed research is to investigate the association between protein intake and nutritional status with bone health and physical functioning in older hip fracture patients. In addition, it will be investigated which patient characteristics and modifiable factors can predict mobility, clinical frailty, living situation and mortality. This study will be a 3-month prospective cohort study in adults aged 70 years and older with an acute hip fracture. This study will lead to knowledge about how protein intake and nutritional status in combination with patient characteristics can predict the degree of recovery (bone health and physical functioning) 3 months after the hip fracture. Knowledge on factors related to recovery can contribute to an improved and shorter rehabilitation in the future, which results in a reduction of health care costs.

NCT ID: NCT05025228 Completed - Femur Fracture Clinical Trials

Analgesic Effect of Paracetamol in Patients With Femur Fracture: is Intravenous Better Than Oral?

Start date: June 1, 2019
Phase:
Study type: Observational

The purpose of this study is to monitor severe pain for femur fracture after treatment with paracetamol IV or OR.

NCT ID: NCT04997785 Completed - Acute Pain Clinical Trials

PENG Block for Traumatic Hip Fracture in the Emergency Department

Start date: August 30, 2021
Phase: N/A
Study type: Interventional

The study is a multicenter single-blinded randomized comparative trial. Adult patients older than 20 years of age presenting with acute hip fracture in emergency department between January 1st, 2021 and December 31st, 2021 will be enrolled. (NOTE: The study was paused temporarily due to local SARS-2 COVID-19 virus pandemic restrictions. Finally, we conducted the study from August 30th, 2021 to May 08th, 2022.) Included patients will receive analgesia with either pericapsular nerve group (PENG) block or intravenous morphine. The primary outcome measure was pain scores (Numeric Rating Scale (NRS) 0 to 10) at rest and with movement. Secondary outcomes were rescue opioids use, complications, length of hospital stay, and patient-reported outcomes.

NCT ID: NCT04995744 Completed - Clinical trials for Patients With Closed Neer Type 4 Proximal Humerus Fractures

Pectoralis Major Pedicle Bone Graft For 4-Part Proximal Humerus Fractures

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The investigators tried to evaluate the results of our patients who underwent plate osteosynthesis with vascularized pectoralis major graft for the treatment of 4-part proximal humerus fractures.

NCT ID: NCT04993053 Completed - Clinical trials for the Cement Augmented Screws of TFNA Nails

Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures

TFNA
Start date: June 20, 2019
Phase:
Study type: Observational

Intramedullary nailing is the standard treatment of trochanteric fractures. Mechanical failure such as cut-out and cut-through are associated with high rates of revision surgery, functional impairment and mortality. Augmentation of the implant have shown encouraging results in reducing the number of mechanical failures. The aim of the study was to evaluate the rate of mechanical failure of the cement augmented screws of TFNA nails. A descriptive, retrospective, multi-operator, single-centre study was performed at our level 1 trauma centre. Patients were included if they were > 65 years of age, presented with a trochanteric fracture treated with an augmented TFNA nail. The primary outcome was fixation failure rate (cut-out or cut-through) at 3 and 6 postoperative months. Secondary endpoints were intraoperative data, clinical scores, and radiographic analysis.